Munich, Germany

Cédric Cheminay

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Cédric Cheminay

Introduction

Cédric Cheminay is a prominent inventor based in Munich, Germany. He holds an impressive portfolio of seven patents that showcase his contributions to the field of vaccine research, particularly in developing innovative solutions to combat viral infections.

Latest Patents

One of Cédric’s latest patents involves a recombinant modified vaccinia virus Ankara (MVA) respiratory syncytial virus (RSV) vaccine. This patent presents genetically engineered MVA vectors that contain nucleotide sequences encoding antigenic determinants of RSV membrane glycoproteins and nucleocapsid proteins. This breakthrough invention provides methods and related products aimed at inducing an immune response in subjects or diagnosing RSV infections, as well as determining the risk of recurrent RSV infections.

Another significant patent released by Cédric focuses on the use of oil and water emulsions to enhance B cell responses with modified Vaccinia Ankara virus. This innovation details compositions and methods for activating an immune response against vaccinia virus, emphasizing that the addition of an oil and water emulsion to MVA significantly boosts B cell responses and neutralizing antibodies. The invention claims encompass administering MVA in an oil and water emulsion to animals, particularly humans, thereby increasing protective immune responses.

Career Highlights

Cédric Cheminay has made substantial advancements in vaccine technology throughout his career, contributing to developing improved immunological strategies. His work at Bavarian Nordic A/S showcases his commitment to enhancing public health through innovative vaccine solutions.

Collaborations

Throughout his journey, Cédric has collaborated with notable colleagues, including Robin Steigerwald and Paul Chaplin. These partnerships emphasize teamwork in research and development, driving forward the advancements in vaccine efficacy and safety.

Conclusion

Cédric Cheminay stands out as an influential figure in the field of vaccine innovation. His ongoing work and numerous patents act as a testament to his dedication to improving vaccine effectiveness and addressing critical public health concerns. Through collaboration and inventive research, Cédric continues to pave the way for future advancements in immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…